BIO:NYE-Bio-Rad Laboratories, Inc (USD)

COMMON STOCK | Medical Devices | NYE

Last Closing Price

USD 538.50

Change

+3.43 (+0.64)%

Market Cap

USD 15.91B

Volume

0.66M

Average Target Price

USD 632.67 (+17.49%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the United States, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Address: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-11-30 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ABT Abbott Laboratories

+0.60 (+0.56%)

USD190.74B 56.91 26.60
MDT Medtronic plc

-0.89 (-0.78%)

USD154.06B 41.82 26.03
SYK Stryker Corporation

+0.59 (+0.25%)

USD87.49B 50.50 29.10
EW Edwards Lifesciences Corporati..

-1.37 (-1.61%)

USD53.14B 67.40 38.94
BSX Boston Scientific Corporation

-0.45 (-1.34%)

USD48.11B 12.90 65.27
ZBH Zimmer Biomet Holdings, Inc

-0.90 (-0.60%)

USD31.10B 814.82 36.46
SNN Smith & Nephew plc

+0.37 (+0.95%)

USD16.98B 43.70 21.14
BIO-B Bio-Rad Laboratories, Inc

+15.02 (+2.86%)

USD15.91B 4.50 3.29
PEN Penumbra, Inc

-4.69 (-2.07%)

USD8.23B 813.79 490.23
BRKR Bruker Corporation

-0.05 (-0.10%)

USD7.76B 50.06 24.85

ETFs Containing BIO

Symbol Name Weight Mer Price(Change) Market Cap
DEUS Xtrackers Russell 1000 Co.. 0.00 % 0.17 %

-0.20 (-0.52%)

USD0.15B
FHH:CA FT AlphaDEX U.S. Health C.. 0.00 % 0.70 %

-0.06 (-0.17%)

USD0.02B
FXH First Trust Health Care A.. 0.00 % 0.62 %

+0.60 (+0.59%)

USD1.30B
IVOO Vanguard S&P Mid-Cap 400 .. 0.00 % 0.10 %

-2.49 (-1.67%)

USD2.05B
SPY4:LSE SPDR S&P 400 US Mid Cap U.. 0.00 % 0.30 %

-0.63 (-0.96%)

USD0.67B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 45.53% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.53% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 44.88% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.88% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 286.10% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 286.10% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 32.03% N/A N/A 96% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.03% N/A N/A 95% A
Risk Return Profile  
Volatility (Standard Deviation) 19.21% N/A N/A 41% F
Risk Adjusted Return 166.72% N/A N/A 99% A+
Market Capitalization 15.91B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 4.59 N/A N/A N/A N/A
Price/Book Ratio 1.81 N/A N/A N/A N/A
Price / Cash Flow Ratio 34.75 N/A N/A N/A N/A
EV/EBITDA 3.29 N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 50.45% N/A N/A N/A N/A
Return on Invested Capital -5.12% N/A N/A N/A N/A
Return on Assets 2.11% N/A N/A N/A N/A
Debt to Equity Ratio 0.24% N/A N/A N/A N/A
Technical Ratios  
Short Ratio 2.48 N/A N/A N/A N/A
Short Percent 1.80% N/A N/A N/A N/A
Beta 1.00 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike